Abstract
Oral administration is a widespread and convenient drug delivery approach. However, oral delivery can be affected by the complex digestive tract environment, including irregular tissue morphology, the presence of digestive enzymes, mucus and mucosal barriers, and spatiotemporal variance in physiological parameters. These obstacles can prevent the oral delivery of many therapeutics. To overcome these challenges, oral delivery devices can be designed with bioinspired compositions, structures or functions to make more drugs available for oral administration. Various bioinspired oral delivery devices have been developed by harnessing biological materials and living microorganisms, or by imitating biological structures and functions. In this Review, we discuss the design and modification of bioinspired oral delivery devices, examining engineering strategies to target specific tissues and applications. We highlight how key bottlenecks in oral delivery can be addressed through bioinspired designs, concluding with an outlook on the remaining challenges towards the clinical translation of bioinspired oral delivery devices.
Key points
-
Biotic components produced by animals, plants and microbes, such as exosomes, pollen grains and bacterial spores, can be used for oral drug delivery and oral vaccination.
-
Living microorganisms can be surface coated, encapsulated or genetically modified to allow oral delivery for the regulation of the intestinal environment, to maintain homeostasis or for disease treatment.
-
Biological materials, such as polysaccharides, peptides, lipids and nucleic acids, including alginate, chitosan, gelatin, liposomes and DNA hydrogels, can improve the efficacy and efficiency of oral delivery devices.
-
Bioinspired chemical components and physical structures can improve the tissue adhesion, permeation and adaption abilities of oral delivery devices.
-
Bioinspired oral delivery devices targeting buccal, oesophageal, gastric and intestinal sites have been preclinically evaluated, and some have entered clinical trials.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Hu, S. et al. A mussel-inspired film for adhesion to wet buccal tissue and efficient buccal drug delivery. Nat. Commun. 12, 1689 (2021).
Choi, H. S. et al. Magnetically guidable proteinaceous adhesive microbots for targeted locoregional therapeutics delivery in the highly dynamic environment of the esophagus. Adv. Funct. Mater. 31, 2104602 (2021).
Abramson, A. et al. An ingestible self-orienting system for oral delivery of macromolecules. Science 363, 611–615 (2019). This article reports the design of a microneedle device that can self-orient, inspired by a leopard tortoise.
Zhang, D. X. et al. Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy. Nat. Commun. 13, 1413 (2022).
Liu, H. et al. Colon-targeted adhesive hydrogel microsphere for regulation of gut immunity and flora. Adv. Sci. 8, 2101619 (2021).
Schafer, A. et al. Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice. Sci. Transl Med. 14, eabm3410 (2022).
Hao, Y. et al. Percutaneous implantation of ethanol fueled catalytic hydrogel suppresses tumor growth by triggering ferroptosis. Mater. Today 55, 7–20 (2022).
Brown, T. D., Whitehead, K. A. & Mitragotri, S. Materials for oral delivery of proteins and peptides. Nat. Rev. Mater. 5, 127–148 (2020).
Xiao, Y. et al. Oral insulin delivery platforms: strategies to address the biological barriers. Angew. Chem. Int. Ed. 59, 19787 (2020).
Xing, L. Y. et al. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs. J. Mater. Chem. B 9, 1707 (2021).
Li, Y., Zhang, W., Zhao, R. C. & Zhang, X. Advances in oral peptide drug nanoparticles for diabetes mellitus treatment. Bioact. Mater. 15, 392–408 (2022).
Qian, C. Y. et al. Vascularized silk electrospun fiber for promoting oral mucosa regeneration. NPG Asia Mater. 12, 39 (2020).
Liu, X. et al. A spider-silk-inspired wet adhesive with super-cold tolerance. Adv. Mater. 33, 2007301 (2021).
Zou, J. J. et al. Efficient oral insulin delivery enabled by transferrin-coated acid-resistant metal-organic framework nanoparticles. Sci. Adv. 8, eabm4677 (2022).
Li, Z. et al. Hydrogel transformed from nanoparticles for prevention of tissue injury and treatment of inflammatory diseases. Adv. Mater. 34, 2109178 (2022).
Fan, W. et al. Mucus penetrating and cell-binding polyzwitterionic micelles as potent oral nanomedicine for cancer drug delivery. Adv. Mater. 34, 2109189 (2022).
Xiao, Y. F. et al. Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes. Matter 4, 3269–3285 (2021).
Zhong, D. N. et al. Orally deliverable strategy based on microalgal biomass for intestinal disease treatment. Sci. Adv. 7, eabi9265 (2021).
Song, Q. L. et al. A probiotic spore-based oral autonomous nanoparticles generator for cancer therapy. Adv. Mater. 31, 1903793 (2019). This article shows that drug-modified Bacillus coagulans spores can autonomously produce drug nanoparticles after germination in the intestine, which contributes to drug permeation and absorption.
Zhang, P. C., Zhao, C. Q., Zhao, T. Y., Liu, M. J. & Jiang, L. Recent advances in bioinspired gel surfaces with superwettability and special adhesion. Adv. Sci. 6, 1900996 (2019).
Wang, Y. P. et al. Cephalopod-inspired chromotropic ionic skin with rapid visual sensing capabilities to multiple stimuli. ACS Nano 15, 3509–3521 (2021).
Yang, L. S. et al. Bioinspired hierarchical porous membrane for efficient uranium extraction from seawater. Nat. Sustain. 5, 71–80 (2022).
Chen, K. et al. Adhesive and injectable hydrogel microspheres for inner ear treatment. Small 18, 2106591 (2022).
Chen, W. et al. Dynamic omnidirectional adhesive microneedle system for oral macromolecular drug delivery. Sci. Adv. 8, eabk1792 (2022). This article reports an oral microneedle device, inspired by thorny-headed worms, which swells after penetration into the intestinal tissue, steadily attaching to the mucosa and continuously delivering drugs.
Zhao, L. et al. Improving drug utilization platform with injectable mucoadhesive hydrogel for treating ulcerative colitis. Chem. Eng. J. 424, 130464 (2021).
Cai, L. J. et al. Boston ivy-inspired disc-like adhesive microparticles for drug delivery. Research 2021, 9895674 (2021).
Wu, J. W. et al. Biomimetic viruslike and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery. ACS Appl. Mater. Interfaces 10, 9916–9928 (2018).
Guo, M. M. et al. Bionic dormant body of timed wake-up for bacteriotherapy in vivo. ACS Nano 16, 823–836 (2022).
Zhong, J. et al. High-quality milk exosomes as oral drug delivery system. Biomaterials 277, 121126 (2021).
Uddin, M. J., Liyanage, S., Abidi, N. & Gill, H. S. Physical and biochemical characterization of chemically treated pollen shells for potential use in oral delivery of therapeutics. J. Pharm. Sci. 107, 3047–3059 (2018).
Li, S. Q. et al. Oral delivery of bacteria: basic principles and biomedical applications. J. Control. Release 327, 801–833 (2020).
Liu, H. et al. Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: advances and perspectives. Bioact. Mater. 14, 169–181 (2022).
Pan, H. Z. et al. Light-sensitive Lactococcus lactis for microbe–gut–brain axis regulating via upconversion optogenetic micro-nano system. ACS Nano 16, 6049–6063 (2022).
Hu, Y., Gao, S., Lu, H. & Ying, J. Y. Acid-resistant and physiological pH-responsive DNA hydrogel composed of A-motif and i-motif toward oral insulin delivery. J. Am. Chem. Soc. 144, 5461–5470 (2022). This article shows that DNA hydrogels can be made acid resistant and pH sensitive for oral insulin delivery by tailoring oligonucleotide sequences.
Liu, Y. X., Sun, L. Y., Zhang, H., Shang, L. R. & Zhao, Y. J. Microfluidics for drug development: from synthesis to evaluation. Chem. Rev. 121, 7468–7529 (2021).
Pandey, M. et al. 3D printing for oral drug delivery: a new tool to customize drug delivery. Drug Deliv. Transl. Res. 10, 986–1001 (2020).
Zhou, X. et al. Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route. Theranostics 9, 6568–6586 (2019).
Luan, Q. et al. Controlled nutrient delivery through a pH-responsive wood vehicle. ACS Nano 16, 2198–2208 (2022).
Sandri, G. et al. An in situ gelling buccal spray containing platelet lysate for the treatment of oral mucositis. Curr. Drug Discov. Technol. 8, 277–285 (2011).
Umezu, T. et al. Acerola exosome-like nanovesicles to systemically deliver nucleic acid medicine via oral administration. Mol. Ther. Methods Clin. Dev. 21, 199–208 (2021).
Mundargi, R. C. et al. Lycopodium spores: a naturally manufactured, superrobust biomaterial for drug delivery. Adv. Funct. Mater. 26, 487–497 (2016).
Kwon, K.-C., Nityanandam, R., New, J. S. & Daniell, H. Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells. Plant Biotechnol. J. 11, 77–86 (2013).
Farjadian, F. et al. Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: set the bugs to work? Biotechnol. Adv. 36, 968–985 (2018).
Akbaria, A. et al. Free and hydrogel encapsulated exosome-based therapies in regenerative medicine. Life Sci. 249, 117447 (2020).
Carobolante, G., Mantaj, J., Ferrari, E. & Vllasaliu, D. Cow milk and intestinal epithelial cell-derived extracellular vesicles as systems for enhancing oral drug delivery. Pharmaceutics 12, 226 (2020).
Kandimalla, R. et al. Targeted oral delivery of paclitaxel using colostrum-derived exosomes. Cancers 13, 3700 (2021).
Huang, L. et al. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. Mol. Cancer 21, 45 (2022).
Nazimek, K., Bryniarski, K., Ptak, W., Kormelink, T. G. & Askenase, P. W. Orally administered exosomes suppress mouse delayed-type hypersensitivity by delivering miRNA-150 to antigen-primed macrophage APC targeted by exosome-surface anti-peptide antibody light chains. Int. J. Mol. Sci. 21, 5540 (2020).
Yan, Y. et al. hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury. Mol. Ther. 25, 465–479 (2017).
Arntz, O. J. et al. Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models. Mol. Nutr. Food Res. 59, 1701–1712 (2015).
Kandimalla, R., Aqil, F., Tyagi, N. & Gupta, R. Milk exosomes: a biogenic nanocarrier for small molecules and macromolecules to combat cancer. Am. J. Reprod. Immunol. 85, e13349 (2021).
Lale, S. V. & Gill, H. S. Pollen grains as a novel microcarrier for oral delivery of proteins. Int. J. Pharm. 552, 352–359 (2018).
Atwe, S. U., Ma, Y. & Gill, H. S. Pollen grains for oral vaccination. J. Control. Release 194, 45–52 (2014).
Franchi, G. G., Franchi, G., Corti, P. & Pompella, A. Microspectrophotometric evaluation of digestibility of pollen grains. Plant Food Hum. Nutr. 50, 115–126 (1997).
Wu, W. et al. In vitro and in vivo digestion comparison of bee pollen with or without wall-disruption. J. Sci. Food Agric. 101, 2744–2755 (2021).
Wu, D., Wang, X. Y., Wang, S. S., Li, B. & Liang, H. S. Nanoparticle encapsulation strategy: leveraging plant exine capsules used as secondary capping for oral delivery. J. Agric. Food Chem. 67, 8168–8176 (2019).
Uddina, M. J. & Gill, H. S. From allergen to oral vaccine carrier: a new face of ragweed pollen. Int. J. Pharm. 545, 286–294 (2018).
Alshehri, S. M. et al. Macroporous natural capsules extracted from Phoenix dactylifera L. spore and their application in oral drugs delivery. Int. J. Pharm. 504, 39–47 (2016).
Gisby, M. F. et al. A synthetic gene increases TGFb3 accumulation by 75-fold in tobacco chloroplasts enabling rapid purification and folding into a biologically active molecule. Plant Biotechnol. J. 9, 618–628 (2011).
Lee, S. B., Li, B., Jin, S. & Daniell, H. Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol. J. 9, 100–115 (2011).
Davoodi-Semiromi, A. et al. Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol. J. 8, 223–242 (2010).
Suzuki, Y. A. et al. Expression, characterization, and biologic activity of recombinant human lactoferrin in rice. J. Pediatr. Gastr. Nutr. 36, 190–199 (2003).
Rome, S. Biological properties of plant-derived extracellular vesicles. Food Funct. 10, 529–538 (2019).
Chen, H. et al. Bacterial ghosts-based vaccine and drug delivery systems. Pharmaceutics 13, 1892 (2021).
Wang, X. P. & Lu, C. P. Mice orally vaccinated with Edwardsiella tarda ghosts are significantly protected against infection. Vaccine 27, 1571–1578 (2009).
Ren, T. Y. et al. Entrapping of nanoparticles in yeast cell wall microparticles for macrophage-targeted oral delivery of cabazitaxel. Mol. Pharm. 15, 2870–2882 (2018).
Yin, L. et al. Bacillus spore-based oral carriers loading curcumin for the therapy of colon cancer. J. Control. Release 271, 31–44 (2018).
Jones, E. J. et al. The uptake, trafficking, and biodistribution of bacteroides thetaiotaomicron generated outer membrane vesicles. Front. Microbiol. 11, 57 (2020).
Shi, J. Y. et al. Biofilm-encapsulated nano drug delivery system for the treatment of colon cancer. J. Microencapsul. 37, 481–491 (2020).
Tong, L. et al. Lactobacillus rhamnosus GG derived extracellular vesicles modulate gut microbiota and attenuate inflammatory in DSS-induced colitis mice. Nutrients 13, 3319 (2021).
Dizman, N. et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat. Med. 28, 704–712 (2022).
Jester, B. W. et al. Development of spirulina for the manufacture and oral delivery of protein therapeutics. Nat. Biotechnol. 40, 956–964 (2022).
Duraj-Thatte, A. M. et al. Programmable microbial ink for 3D printing of living materials produced from genetically engineered protein nanofibers. Nat. Commun. 12, 6600 (2021).
Fan, G., Wasuwanich, P., Rodriguez-Otero, M. R. & Furst, A. L. Protection of anaerobic microbes from processing stressors using metal–phenolic networks. J. Am. Chem. Soc. 144, 2438–2443 (2022). This article reports surface-modified metal–phenolic networks that protect anaerobic microbes from oxygen toxicity, ensuring their bioactivity after oral administration.
Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229–236 (2020).
Zheng, D. W. et al. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure. Nat. Biomed. Eng. 4, 853–862 (2020). This article reports the encapsulation of three faecal bacteria strains in a hydrogel microsphere that, after oral administration, can eliminate nitrogenous waste products and treat kidney failure in pigs.
Martín, M. et al. Magnetic study on biodistribution and biodegradation of oral magnetic nanostructures in the rat gastrointestinal tract. Nanoscale 8, 15041 (2016).
Yue, Y. et al. Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria. Nat. Biomed. Eng. 6, 898–909 (2022).
Pan, J. et al. A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea. Nat. Commun. 13, 2117 (2022).
Wang, X. Y. et al. Bioinspired oral delivery of gut microbiota by self-coating with biofilms. Sci. Adv. 6, eabb1952 (2020).
Song, Q. L. et al. A bioinspired versatile spore coat nanomaterial for oral probiotics delivery. Adv. Funct. Mater. 31, 2104994 (2021).
Liu, J. et al. Biomaterials coating for on-demand bacteria delivery: selective release, adhesion, and detachment. Nano Today 41, 101291 (2021).
Centurion, F. et al. Cell-Mediated biointerfacial phenolic assembly for probiotic nano encapsulation. Adv. Funct. Mater. 32, 2200775 (2022).
Zhang, Y. et al. Temulence therapy to orthotopic colorectal tumor via oral administration of fungi-based acetaldehyde generator. Small Methods 6, 2100951 (2022).
Talebian, S. et al. Biopolymer-based multilayer microparticles for probiotic delivery to colon. Adv. Healthc. Mater. 11, 2102487 (2022).
Cheng, Q. et al. A colon-targeted oral probiotics delivery system using an enzyme-triggered fuse-like microcapsule. Adv. Healthc. Mater. 10, 2001953 (2021).
Verma, A. et al. Angiotensin-(1–7) expressed from Lactobacillus bacteria protect diabetic retina in mice. Trans. Vis. Sci. Tech. 9, 20 (2020).
Fan, J. X. et al. Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-α expression via oral administration. Nano Lett. 18, 2373–2380 (2018).
Cubillos-Ruiz, A. et al. An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis. Nat. Biomed. Eng. 6, 910–921 (2022).
Din, M. et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature 536, 81–85 (2016). This article demonstrates periodic drug release through the introduction of a timing circuit in genetically engineered bacteria.
Drolia, R. et al. Receptor-targeted engineered probiotics mitigate lethal Listeria infection. Nat. Commun. 11, 6344 (2020).
Mao, N., Cubillos-Ruiz, A., Cameron, D. E. & Collins, J. J. Probiotic strains detect and suppress cholera in mice. Sci. Transl Med. 10, eaao2586 (2018).
Danino, T. et al. Programmable probiotics for detection of cancer in urine. Sci. Transl Med. 7, 289ra84 (2015).
Barclay, T. G., Day, C. M., Petrovsky, N. & Garg, S. Review of polysaccharide particle-based functional drug delivery. Carbohyd. Polym. 221, 94–112 (2019).
Voci, S., Fresta, M. & Cosco, D. Gliadins as versatile biomaterials for drug delivery applications. J. Control. Release 329, 385–400 (2021).
Fattahi, N. et al. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines. J. Control. Release 326, 556–598 (2020).
Cai, L. et al. Suction-cup-inspired adhesive micromotors for drug delivery. Adv. Sci. 9, 2103384 (2022).
Xu, J., Strandman, S., Zhu, J. X. X., Barralet, J. & Cerruti, M. Genipin-crosslinked catechol-chitosan mucoadhesive hydrogels for buccal drug delivery. Biomaterials 37, 395–404 (2015).
Zhang, X. X., Chen, G. P., Fu, X., Wang, Y. T. & Zhao, Y. J. Magneto-responsive microneedle robots for intestinal macromolecule delivery. Adv. Mater. 33, 2104932 (2021).
Shtenberg, Y. et al. Mucoadhesive alginate pastes with embedded liposomes for local oral drug delivery. Int. J. Biol. Macromol. 111, 62–69 (2018).
Song, Q. L. et al. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy. Nanoscale 11, 15958 (2019).
Yin, H. S. et al. Smart pH-sensitive hydrogel based on the pineapple peel-oxidized hydroxyethyl cellulose and the hericium erinaceus residue carboxymethyl chitosan for use in drug delivery. Biomacromolecules 23, 253–264 (2022).
Wang, C. P. J. et al. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. J. Control. Release 345, 1–19 (2022).
Zhang, Y. et al. Layer-by-layer coated nanoliposomes for oral delivery of insulin. Nanoscale 13, 776–789 (2021).
Li, B. et al. Micro-ecology restoration of colonic inflammation by in-situ oral delivery of antibody-laden hydrogel microcapsules. Bioact. Mater. 15, 305–315 (2022).
Yang, K. et al. Prebiotics and postbiotics synergistic delivery microcapsules from microfluidics for treating colitis. Adv. Sci. 9, 2104089 (2022).
Kenechukwu, F. C., Dias, M. L. & Ricci-Júnior, E. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs. Carbohyd. Polym. 256, 117492 (2021).
Pooresmaeil, M. & Namazi, H. Developments on carboxymethyl starch-based smart systems as promising drug carriers: a review. Carbohyd. Polym. 258, 117654 (2021).
Layek, B. & Mandal, S. Natural polysaccharides for controlled delivery of oral therapeutics: a recent update. Carbohyd. Polym. 230, 115617 (2020).
Tang, R. C., Chen, T. C. & Lin, F. H. Design strategy for a hydroxide-triggered pH-responsive hydrogel as a mucoadhesive barrier to prevent metabolism disorders. ACS Appl. Mater. Interfaces 13, 58340–58351 (2021).
Zhao, C. et al. Biomimetic intestinal barrier based on microfluidic encapsulated sucralfate microcapsules. Sci. Bull. 64, 1418 (2019).
Gan, J. J. et al. Orally administrated nucleotide-delivery particles from microfluidics for inflammatory bowel disease treatment. Appl. Mater. Today 25, 101231 (2021).
Hou, Y. et al. Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer. Biomaterials 283, 121440 (2022).
Wong, C. Y., Al-Salami, H. & Dass, C. R. The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation. J. Drug Target. 26, 551–562 (2018).
Cesar, A. L. A. et al. New mesalamine polymeric conjugate for controlled release: preparation, characterization and biodistribution study. Eur. J. Pharm. Sci. 111, 57–64 (2018).
Grigoras, A. G. Drug delivery systems using pullulan, a biocompatible polysaccharide produced by fungal fermentation of starch. Environ. Chem. Lett. 17, 1209–1223 (2019).
Wu, Y. et al. Bioinspired β-glucan microcapsules deliver FK506 to lymph nodes for treatment of cardiac allograft acute rejection. Biomater. Sci. 8, 5282 (2020).
Cao, Y. & Mezzenga, R. Design principles of food gels. Nat. Food 1, 106–118 (2020).
Gao, C. et al. A directly swallowable and ingestible micro-supercapacitor. J. Mater. Chem. A 8, 4055–4061 (2020).
Khan, F. Y., Jan, S. M. & Mushtaq, M. Clinical utility of locally-delivered collagen-based biodegradable tetracycline fibers in periodontal therapy: an in vivo study. J. Investig. Clin. Dent. 6, 307–312 (2015).
Xu, S. et al. Genetically engineered pH-responsive silk sericin nanospheres with efficient therapeutic effect on ulcerative colitis. Acta Biomater. 144, 81–95 (2022).
Huang, J. et al. Layer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine. Biomaterials 39, 105–113 (2015).
Wei, Z. & Huang, Q. Assembly of protein−polysaccharide complexes for delivery of bioactive ingredients: a perspective paper. J. Agric. Food Chem. 67, 1344–1352 (2019).
Alqahtani, M. S. et al. Food protein based core–shell nanocarriers for oral drug delivery: effect of shell composition on in vitro and in vivo functional performance of zein nanocarriers. Mol. Pharm. 14, 757–769 (2017).
Bunjes, H. Lipid nanoparticles for the delivery of poorly water-soluble drugs. J. Pharm. Pharmacol. 62, 1637–1645 (2010).
Casadei, M. A. et al. Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations. Int. J. Pharm. 325, 140–146 (2006).
Fu, X. et al. mRNA delivery by a pH-responsive DNA nano-hydrogel. Small 17, 2101224 (2021).
Mo, F. L. et al. DNA hydrogel-based gene editing and drug delivery systems. Adv. Drug Deliv. Rev. 168, 79–98 (2021).
Jiang, X. et al. Self-assembled DNA-THPS hydrogel as a topical antibacterial agent for wound healing. ACS Appl. Bio Mater. 2, 1262–1269 (2019).
English, M. A. et al. Programmable CRISPR-responsive smart materials. Science 365, 780–785 (2019).
Nomura, D. et al. Development of orally-deliverable DNA hydrogel by microemulsification and chitosan coating. Int. J. Pharm. 547, 556 (2018).
Ghosh, A. et al. Gastrointestinal-resident, shape-changing microdevices extend drug release in vivo. Sci. Adv. 6, eabb4133 (2020).
Zhao, C. et al. Cheerios effect inspired microbubbles as suspended and adhered oral delivery systems. Adv. Sci. 8, 2004184 (2021).
Ryu, J. H. et al. Chitosan oral patches inspired by mussel adhesion. J. Control. Release 317, 57–66 (2020).
Wang, Y. T. et al. Pollen-inspired microparticles with strong adhesion for drug delivery. Appl. Mater. Today 13, 303–309 (2018).
Mathiowitz, E. et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature 386, 410–414 (1997).
Zhao, P. et al. Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy. Nat. Commun. 12, 7162 (2021).
Li, J. et al. Gastrointestinal synthetic epithelial linings. Sci. Transl Med. 12, eabc0441 (2020).
Liu, C. et al. Design of virus-mimicking polyelectrolyte complexes for enhanced oral insulin delivery. J. Pharm. Sci. 108, 3408–3415 (2019).
Lamson, N. G., Berger, A., Fein, K. C. & Whitehead, K. A. Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability. Nat. Biomed. Eng. 4, 84–96 (2020).
Yang, Y. et al. Rapid transport of germ-mimetic nanoparticles with dual conformational polyethylene glycol chains in biological tissues. Sci. Adv. 6, eaay9937 (2020).
Menina, S. et al. Bioinspired liposomes for oral delivery of colistin to combat intracellular infections by salmonella enterica. Adv. Healthc. Mater. 8, 1900564 (2019).
Shen, Y. R., Hu, Y. M. & Qiu, L. Y. Nano-vesicles based on phospholipid-like amphiphilic polyphosphazenes to orally deliver ovalbumin antigen for evoking anti-tumor immune response. Acta Biomater. 106, 267–277 (2020).
Zhu, X. et al. Sub-50 nm nanoparticles with biomimetic surfaces to sequentially overcome the mucosal diffusion barrier and the epithelial absorption barrier. Adv. Funct. Mater. 26, 2728–2738 (2016).
Surwase, S. S. et al. Engineered nanoparticles inside a microparticle oral system for enhanced mucosal and systemic immunity. ACS Appl. Mater. Interfaces 14, 11124–11143 (2022).
Zhao, C., Chen, G. P., Wang, H., Zhao, Y. J. & Chai, R. J. Bio-inspired intestinal scavenger from microfluidic electrospray for detoxifying lipopolysaccharide. Bioact. Mater. 6, 1653–1662 (2021).
Ze, Q. et al. Soft robotic origami crawler. Sci. Adv. 8, eabm7834 (2022).
Abramson, A. et al. Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections. Matter 5, 1–13 (2022).
Byeon, J. C. et al. Recent formulation approaches to oral delivery of herbal medicines. J. Pharm. Investig. 49, 17–26 (2019).
Miao, Y. B. et al. Engineering nano- and microparticles as oral delivery vehicles to promote intestinal lymphatic drug transport. Adv. Mater. 33, 2104139 (2021).
Valverde, M. G. et al. Biomimetic models of the glomerulus. Nat. Rev. Nephrol. 18, 241–257 (2022).
He, M., Zhu, L., Yang, N., Li, H. & Yang, Q. Recent advances of oral film as platform for drug delivery. Int. J. Pharm. 604, 120759 (2021).
Hua, S. Advances in drug formulation of the sublingual and buccal routes for gastrointestinal drug delivery. Front. Pharmacol. 10, 1328 (2019).
Fonseca-Santos, B. & Chorilli, M. An overview of polymeric dosage forms in buccal drug delivery: state of art, design of formulations and their in vivo performance evaluation. Mater. Sci. Eng. C. Mater. Biol. Appl. 86, 129–143 (2018).
Jacob, S. et al. An updated overview of the emerging role of patch and film-based buccal delivery systems. Pharmaceutics 13, 1206 (2021).
Nguyen, O. O. T. et al. Oral cavity: an open horizon for nanopharmaceuticals. J. Pharm. Invest. 51, 413–424 (2021).
Camargo, L. G. et al. Development of bioadhesive polysaccharide-based films for topical release of the immunomodulatory agent imiquimod on oral mucosa lesions. Eur. Polym. J. 151, 110422 (2021).
Alrimawi, B. H., Chan, M. Y., Ooi, X. Y., Chan, S. Y. & Goh, C. F. The interplay between drug and sorbitol contents determines the mechanical and swelling properties of potential rice starch films for buccal drug delivery. Polymers 13, 578 (2021).
Macedo, A. S. et al. Novel and revisited approaches in nanoparticle systems for buccal drug delivery. J. Control. Release 320, 125–141 (2020).
Oezcelik, A. & DeMeester, S. R. General anatomy of the esophagus. Thorac. Surg. Clin. 21, 289–297 (2011).
Liu, H. et al. Esophagus-Inspired actuator for solid transportation via the synergy of lubrication and contractile deformation. Adv. Sci. 8, 2102800 (2021).
Lin, C., Liu, W., Xie, J., Li, W. & Zhou, Z. The lubricating function of mucin at the gastroscope device-esophagus interface. Tribol. Lett. 68, 82 (2020).
Lottrup, C., Khan, A., Rangan, V. & Clarke, J. O. Esophageal physiology–an overview of esophageal disorders from a pathophysiological point of view. Ann. NY Acad. Sci. 1481, 182–197 (2020).
Raman, R. et al. Light-degradable hydrogels as dynamic triggers for gastrointestinal applications. Sci. Adv. 6, eaay0065 (2020).
Babaee, S. et al. Temperature-responsive biometamaterials for gastrointestinal applications. Sci. Transl Med. 11, eaau8581 (2019). This article reports a flower-like, shape-memory, reconfigurable oesophageal delivery device that remains folded during oral administration, deploys to penetrate the mucosa and deliver drugs, and refolds upon contact with warm water.
Sathish, D., Himabindu, S., Kumar, Y. S., Shayeda & Rao, Y. M. Floating drug delivery systems for prolonging gastric residence time: a review. Curr. Drug Deliv. 8, 494–510 (2011).
Prescott, L. F. Gastrointestinal absorption of drugs. Med. Clin. North Am. 58, 907–916 (1974).
Chen, Q. et al. SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs. Cell. Res. 31, 247–258 (2021).
Biswas, N. & Sahoo, R. K. Tapioca starch blended alginate mucoadhesive-floating beads for intragastric delivery of Metoprolol Tartrate. Int. J. Biol. Macromol. 83, 61–70 (2016).
Abramson, A. et al. Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors. Nat. Biotechnol. 40, 103–109 (2022).
Angsantikul, P. et al. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against helicobacter pylori infection. Adv. Therap. 1, 1800016 (2018).
Cheng, Z. J. et al. Fabrication of ulcer-adhesive oral keratin hydrogel for gastric ulcer healing in a rat. Regen. Biomater. 8, rbab008 (2021).
Walker, D., Käsdorf, B. T., Jeong, H.-H., Lieleg, O. & Fischer, P. Enzymatically active biomimetic micropropellers for the penetration of mucin gels. Sci. Adv. 1, e150050 (2015).
Choi, H., Jeong, S. H., Kim, T. Y., Yi, J. & Hahn, S. K. Bioinspired urease-powered micromotor as an active oral drug delivery carrier in stomach. Bioact. Mater. 9, 54–62 (2022).
de Ávila, B. E. F. et al. Micromotor-enabled active drug delivery for in vivo treatment of stomach infection. Nat. Commun. 8, 272 (2017). This article reports clarithromycin-loaded gastric micromotors that are propelled by the gas-producing reaction of Mg and H+ to release drugs in the stomach for the treatment of H. pylori infection.
Stojanović, O. et al. Dietary excess regulates absorption and surface of gut epithelium through intestinal PPARα. Nat. Commun. 12, 7031 (2021).
Lee, S. H. et al. Strategic approaches for colon targeted drug delivery: an overview of recent advancements. Pharmaceutics 12, 68 (2020).
Maher, S., Mrsny, R. J. & Brayden, D. J. Intestinal permeation enhancers for oral peptide delivery. Adv. Drug Deliv. Rev. 106, 277–319 (2016).
Hewes, S. A. et al. In vitro models of the small intestine: engineering challenges and engineering solutions. Tissue Eng. Part B Rev. 26, 313–326 (2020).
Yue, H., Chang, X., Liu, J., Zhou, D. & Li, L. Wheel-like magnetic-driven microswarm with a band-aid imitation for patching up microscale intestinal perforation. ACS Appl. Mater. Interfaces 14, 8743–8752 (2022).
Gagnière, J. et al. Gut microbiota imbalance and colorectal cancer. World J. Gastroenterol. 22, 501–518 (2016).
Paulraj, T., Riazanova, A. V. & Svagan, A. J. Bioinspired capsules based on nanocellulose, xyloglucan and pectin–the influence of capsule wall composition on permeability properties. Acta Biomater. 69, 196–205 (2018).
Ma, Y. et al. Oral nanotherapeutics based on Antheraea pernyi silk fibroin for synergistic treatment of ulcerative colitis. Biomaterials 282, 121410 (2022).
Zhou, J. J. et al. An injectable peptide hydrogel constructed of natural antimicrobial peptide J-1 and ADP shows anti-infection, hemostasis, and antiadhesion efficacy. ACS Nano 16, 7636–7650 (2022).
Yu, J. et al. Active generation and magnetic actuation of microrobotic swarms in bio-fluids. Nat. Commun. 10, 5631 (2019).
Wu, Z. et al. A swarm of slippery micropropellers penetrates the vitreous body of the eye. Sci. Adv. 4, eaat4388 (2018).
Schudel, A. et al. Programmable multistage drug delivery to lymph nodes. Nat. Nanotechnol. 15, 491–499 (2020).
Luo, C. et al. Stimulus-responsive nanomaterials containing logic gates for biomedical applications. Cell Rep. Phys. Sci. 2, 100350 (2021).
Zhang, P. et al. A programmable polymer library that enables the construction of stimuli-responsive nanocarriers containing logic gates. Nat. Chem. 12, 381–390 (2020).
Harimoto, T. et al. A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat. Biotechnol. 40, 1259–1269 (2022).
Nikolaev, M. et al. Homeostatic mini-intestines through scaffold-guided organoid morphogenesis. Nature 585, 574–578 (2020).
Jing, B. et al. Chitosan oligosaccharides regulate the occurrence and development of enteritis in a human gut-on-a-chip. Front. Cell Dev. Biol. 10, 877892 (2022).
Ronaldson-Bouchard, K. et al. A multi-organ chip with matured tissue niches linked by vascular flow. Nat. Biomed. Eng. 6, 351–371 (2022).
Joslin, E. P. The routine treatment of diabetes with insulin. J. Am. Med. Assoc. 80, 1581–1583 (1923).
Harrison, G. A. Insulin in alcoholic solution by the mouth. Br. Med. J. 1923, 1204–1205 (1923).
Eiseman, B., Silen, W., Bascom, G. S. & Kauvar, A. J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44, 854–859 (1958).
Donlan, A. N. & Petri, W. A. Jr. Mucosal immunity and the eradication of polio. Science 368, 362–363 (2020).
Sessa, G. & Weissmann, G. Phospholipid spherules (liposomes) as a model for biological membranes. J. Lipid Res. 9, 310–318 (1968).
Gregoriadis, G. & Ryman, B. Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem. J. 124, 58 (1971).
Cohen, S. N., Chang, A. C. Y., Boyer, H. W. & Helling, R. B. Construction of biologically functional bacterial plasmids in vitro. Proc. Natl Acad. Sci. USA 70, 3240–3244 (1973).
Dapergolas, G. & Gregoriadis, G. Hypoglycemic effect of liposome-entrapped insulin administrated intragastrically into rats. Lancet 2, 824–827 (1976).
Pan, B. T. & Johnstone, R. M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33, 967–978 (1983).
Hari, P. R., Chandy, T. & Sharma, C. P. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencapsul. 13, 319–329 (1996).
Cassandra, W. How antiviral pill molnupiravir shot ahead in the COVID drug hunt. Nature https://doi.org/10.1038/d41586-021-02783-1 (2021). This news article reports the first oral antiviral COVID-19 treatment.
Zhong, H., Chan, G., Hu, Y., Hu, H. & Ouyang, D. A comprehensive map of FDA-approved pharmaceutical products. Pharmaceutics 10, 263 (2018).
Ebied, A. M., Elmariah, H. & Cooper-DeHoff, R. M. New drugs approved in 2021. Am. J. Med. 135, 836–839 (2022).
Zocco, M. A. et al. Efficacy of lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 23, 1567–1574 (2006).
Braat, H. et al. A phase I trial with transgenic bacteria expressing Interleukin-10 in Crohn’s disease. Clin. Gastroenterol. Hepatol. 4, 754–759 (2006).
Acknowledgements
This work was supported by the National Key Research and Development Program of China (2020YFA0908200), the National Natural Science Foundation of China (T2225003 and 52073060), the Guangdong Basic and Applied Basic Research Foundation (2021B1515120054) and the Shenzhen Fundamental Research Program (JCYJ20190813152616459 and JCYJ20210324133214038).
Author information
Authors and Affiliations
Contributions
X.Z. gathered information, wrote the manuscript, and prepared the figures and tables. G.C. discussed the manuscript and drafted the figures. H.Z. edited the manuscript. L.S. discussed and edited the manuscript. Y.Z. conceived the concept and reviewed the outline.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Bioengineering thanks Guangjun Nie, Giovanni Traverso, So-Yoon Yang, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
Dexedrine: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017078
Guidance for industry and food and drug administration staff: applying human factors and usability engineering to medical devices: https://www.fda.gov/media/80481/download
Guidance for industry: design and analysis of shedding studies for virus or bacteria-based gene therapy and oncolytic products: https://www.fda.gov/media/89036/download
Guidance for industry: size, shape, and other physical attributes of generic tablets and capsules: https://www.fda.gov/media/87344/download
NIH guidelines for research involving recombinant or synthetic nucleic acid molecules: https://osp.od.nih.gov/wp-content/uploads/NIH_Guidelines.pdf
Plenity establishment registration and device listing: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=644831&lpcd=QFQ
Rapamune: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021110
Rybelsus: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051
S6(R1) Preclinical safety evaluation of biotechnology-derived pharmaceuticals: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/s6r1-preclinical-safety-evaluation-biotechnology-derived-pharmaceuticals
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, X., Chen, G., Zhang, H. et al. Bioinspired oral delivery devices. Nat Rev Bioeng 1, 208–225 (2023). https://doi.org/10.1038/s44222-022-00006-4
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s44222-022-00006-4
This article is cited by
-
Engineering bacteria for enhanced tumor therapy: from surface modification to synthetic genetic circuits
Journal of Hematology & Oncology (2025)
-
Living plastics from plasticizer-assisted thermal molding of silk protein
Nature Communications (2025)
-
Oral dosage forms for drug delivery to the colon: an existing gap between research and commercial applications
Journal of Materials Science: Materials in Medicine (2025)
-
Advanced material technologies for space and terrestrial medicine
Nature Reviews Materials (2024)
-
Intestinal organ chips for disease modelling and personalized medicine
Nature Reviews Gastroenterology & Hepatology (2024)


